跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 94,195 条关于
“Sarepta Therapeutics gene therapy”
全部
94,195
临床试验
61,167
药物
7,762
机构
1,254
资讯
24,012
去年
FDA Reinstates Sarepta's Elevidys Gene Therapy Following Parent Advocacy Despite Failed Trial
2年前
Sarepta's Gene Therapy Fails Primary Endpoint in Duchenne Muscular Dystrophy Trial
去年
FDA Official Dr. Vinay Prasad Resigns After Three Months Amid Sarepta Gene Therapy Controversy
去年
Arrowhead Pharmaceuticals Weathers Sarepta Partnership Turbulence as $11 Billion RNAi Deal Faces Market Scrutiny
10个月前
FDA Leadership Turmoil Escalates as Richard Pazdur Takes CDER Helm Amid Pfizer-Novo Bidding War
去年
Elevidys Fails to Meet Primary Endpoint in Phase 3 EMBARK Trial for Duchenne Muscular Dystrophy
去年
Duchenne Muscular Dystrophy: Biotech Firms Advance Novel Therapies
2年前
Duchenne Muscular Dystrophy: Balancing Gene Therapy's Promise with Evolving Treatment Landscape
2年前
Capricor Therapeutics Gains FDA Alignment on HOPE-3 Trial Design for CAP-1002 in Duchenne Muscular Dystrophy
3个月前
Acting FDA Commissioner Kyle Diamantas Meets with Rare Disease Groups to Repair Strained Relations
第 1 页，共 2402 页
上一页
下一页
